Ultrapar CEO outlines 'patient capital' M&A strategy through 2031

Ultrapar's CEO Rodrigo Pizzinatto emphasizes a disciplined M&A approach, having reviewed over 100 deals but closing only 14 in five years, prioritizing value creation over growth. This signals a conservative capital allocation strategy for the Brazilian conglomerate, potentially impacting its growth trajectory and investor expectations.